MAGI2 and Alzheimer disease: Serum levels of MAGI2-AS3 and miR-374b-5p in Alzheimer’s patients were negatively correlated and associated with disease severity, suggesting the MAGI2-AS3/miR-374b-5p axis as a potential biomarker and therapeutic target for AD [156].